Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats

British Journal of Pharmacology

Volumn 118, Issue 2, 1996, Pages 255-260

  Hiramatsu, M ^a   Mori, H ^a   Murasawa, H ^a   Kameyama, T ^a  

^a MEIJO UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Dynorphin A (1 13); Galanin; Hippocampus; In vivo microdialysis; Kappa opioid receptor; Learning and memory

Indexed keywords

ACETYLCHOLINE; DYNORPHIN[1-13]; GALANIN; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE; OPIATE ANTAGONIST;

ACETYLCHOLINE RELEASE; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; LEARNING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECALL;

EID: 0029875977     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15396.x     Document Type: Article

References (53)

1. + or glutamic acid from rat neostriatal slices. Brain Res., 523, 51-56.
2. ASPLEY, S. & FONE, K.C.F (1993). Galanin fails to alter both acquisition of a two trial per day water maze task and neurochemical markers of cholinergic or serotonergic neurones in adult rats. Brain Res., 622, 330-336.
3. BARTUS, R.T., DEAN, R.L., BEER, B. & LIPPA, A.S. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-417.
4. BEAL, M.F., MACGARVEY, U. & SWARTZ, K.J. (1990). Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease. Ann. Neurol., 28, 157-161.
5. CHAN-PALAY, V. (1988). Galanin hyper-innervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. Comp. Neurol., 273, 543-557.
6. COLOMBO, P.J., MARTINEZ, J.L. Jr, BENNETT, E.L. & ROSENZWEIG, M.R. (1992). Kappa opioid receptor activity modulates memory for peck-avoidance training in the 2-day-old chick. Psychopharmacology, 108, 235-240.
7. CONSOLO, S., BALDI, G., RUSSI, G., CIVENNI, G. & BARTFAI, T. (1994). Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc. Natl. Acad. Sci. U.S.A., 91, 8047-8051.
8. CONSOLO, S., BERTORELLI, R., GIROTTI, P., LA PORTA, C. BARTFAI, T., PARENTI, M. & ZAMBELLI, M. (1991). Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat ventral hippocampus. Neurosci. Lett., 126, 29-32.
9. CRAWLEY, J.B. & WENK, G.L. (1989). Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci., 12, 278-282.
10. DUTAR, P., LAMOUR, Y. & NICOLL, R.A. (1989). Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur. J. Pharmacol., 164, 355-360.
11. FISONE, G., BARTFAI, T., NILSSON, S. & HÖKFELT, T. (1991). Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res., 568, 279-284.
12. FISONE, G., WU C.F., CONSOLO, S., NORDSTRÖM Ö., BRYNNE, N., BARTFAI, T., MELANDER, T. & HÖKFELT, T. (1987). Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: Histochemical, autoradiographic, in vivo, and in vitro studies. Proc. Natl. Acad. Sci. U.S.A., 84, 7339-7343.
13. FUJIMORI, K. & YAMAMOTO, K. (1987). Determination of acetylcholine and choline in perchlorate extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J. Chromatgr., 414, 167-173.
14. GABRIEL, S.M., BIERER, L.M., DAVIDSON, M., PUROHIT, D.P., PERL, D.P. & HAROTUNIAN, V. (1994). Galanin-like immuno reactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease. J. Neurochem., 62, 1516-1523.
15. GIVENS, B.S., OLTON, D.S. & CRAWLEY, J.N. (1992). Galanin in the medial septal area impairs working memory. Brain Res., 582, 71-77.
16. HEIJNA, M.H., PADT, M., HOGENBOOM, F., PORTOGHESE, P.S., MULDER, A.H. & SCHOFFELMEER, A.N.M. (1990). Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur. J. Pharmacol., 181, 267-278.
17. HILLER, J.M., ITZHAK, Y. & SIMON, E.J. (1987). Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. Brain Res., 406, 17-23.
18. HIRAMATSU, M., KAMEYAMA, T. & NABESHIMA, T. (1994). Experimental techniques for developing new drugs acting on dementia (6) - Carbon monoxide-induced amnesia model in experimental animals. Jpn. J. Psychopharmacol., 14, 305-313.
19. HIRAMATSU, M., KOIDE, T., ISHIHARA, S., SHIOTANI, T., KAMEYAMA, T. & NABESHIMA, T. (1992). Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia. Eur. J. Pharmacol., 216, 279-285.
20. HIRAMATSU, M., SASAKI, M. & KAMEYAMA, T. (1995). Effects of dynorphin A (1-13) on carbon monoxide (CO)-induced delayed amnesia in mice using a step-down type passive avoidance task. Eur. J. Pharmacol., 282, 185-191.
21. INTROINI-COLLISON, I.B., CAHILL, L., BARATTI, C.M. & MCGAUGH, J.L. (1987). Dynorphin induces task-specific impairment of memory. Psychobiology, 15, 171-176.
22. ITOH, J., UKAI, M. & KAMEYAMA, T. (1993). Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur. J. Pharmacol., 236, 341-345.
23. IZQUIERDO, I., DE ALMEIDA, M.A.M.R. & EMILIANO, V.R. (1985). Unlike β-endorphin, dynorphin 1-13 does not cause retrograde amnesia for shuttle avoidance or inhibitory avoidance learning in rats. Psychopharmacology, 87, 216-218.
24. IZQUIERDO, I., PAIVA, A.C.M. & ELISABETSKY, E. (1980). Post training intraperitoneal administration of leu-enkephalin and β-endorphin causes retrograde amnesia for two different tasks in rats. Behav. Neural Biol., 28, 246-250.
25. JIANG, H.-K., OWYANG, V., HONG, J.-S. & GALLACHER, M. (1989). Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc. Natl. Acad. Sci. U.S.A., 86, 2948-2951.
26. JOHNSTON, M.V., MCKINNEY, M. & COYLE, J.T. (1979). Evidence for a cholinergic projection to neo-cortex from neurons in basal forebrain. Proc. Natl. Acad. Sci. U.S.A., 76, 5392-5396.
27. KAMEYAMA, T., HIRAMATSU, M. & SASAKI, M. (1994a). Effects of dynorphin A (1-13) on the carbon monoxide (CO)-induced impairment of spontaneous alternation performance in mice. Can. J. Physiol. Pharmacol., 72 (Suppl. 1), 406.
28. KAMEYAMA, T., UKAI, M. & MIURA, M. (1994b). Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice. Neuropharmacology, 33, 1167-1169.
29. LAPCHAK, P.A., ARAUJO, D.M. & COLLIER, B. (1989). Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat. Neuroscience, 31, 313-325.
30. MASTROPAOLO, J., NADI, N.S., OSTROWSKI, N.L. & CRAWLEY, J.N. (1988). Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc. Natl. Acad. Sci. U.S.A., 85, 9841-9845.
31. MELANDER, T., HÖKFELT, T., RÖKAEUS, A., FAHRENKRUG, J., TATEMOTO, K. & MUTT, V. (1985a). Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res., 239, 253-270.
32. MELANDER, T., HÖKFELT, T., RÖKAEUS, A., CUELLO, A.C., OERTEL, W.H., VERHOFSTAD, A. & GOLDSTEIN, M. (1986a). Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J. Neurosci., 6, 3640-3654.
33. MELANDER, T., STAINES, W.A., HÖKFELT, T., RÖKAEUS, A., ECKENSTEIN, F., SALVATERRA, P.M. & WAINER, B.H. (1985b). Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res., 360, 130-138.
34. MELANDER, T., STAINES, W.A. & RÖKAEUS, A. (1986b). Galanin-like immunoreactivity in hippocampal afferents in the rat with special reference to cholinergic and noradrenergic inputs. Neuroscience, 19, 223-240.
35. MORI, H., HIRAMATSU, M., MURASAWA, H. & KAMEYAMA, T. (1995). Dynorphin A (1-13) abolishes galanin-induced decrease of acetylcholine release in the rat brain. Jpn. J. Pharmacol, 67 (Suppl. I), 229P.
36. MORI, H., HIRAMATSU, M., SUZUKI, H. & KAMEYAMA, T. (1993). Changes in monoamine concentrations in brain induced by dynorphin A (1-13) using in vivo microdialysis. Folia Pharmacol, Jpn., 102, 88P.
37. MULDER, A.H., BURGER, D.M., WARDEH, G., HOGENBOON, F. & FRANKHUYZEN, A.L. (1991). Pharmacological profile of various κ-agonists at κ-, μ- and δ-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br. J. Pharmacol., 102, 518-522.
38. MULDER, A.H., WARDEH, G., HOGENBOON, E. & FRANKHUYZEN, A.L. (1984).κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature, 308, 278-280.
39. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. New York:Academic Press.
40. RIGTER, H., HANNAN, T.J., MESSING, R.B., MARTINEZ, J.L. Jr, VASQUEZ, B.J., JENSEN, R.A., VELIQUETTE, J. & MCGAUGH, J.L. (1980). Enkephalins interfere with acquisition of an active avoidance response. Life Sci., 26, 337-345.
41. ROBINSON, J.K. & CRAWLEY, J.N. (1993). Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats. Behav. Neurosci., 107, 458-467.
42. RÖKAEUS, A. (1987). Galanin: a newly isolated biologically active neuropeptide. Trends Neurosci., 10, 158-164.
43. RÖKAEUS, A., MELANDER, T., HÖKFELT, T., LUNDBERG, J.M., TATEMOTO, K., CARLQUIST, M. & MUTT, V. (1984). A galanin-like peptide in the central nervous system and intestine of the rat. Neurosci. Lett., 47, 161-166.
44. SARTER, M. (1991). Taking stock of cognition enhancers. Trends Pharmacol. Sci., 12, 456-461.
45. SCHOFFELMEER, A.N.M., RICE, K.C., JACOBSON, A.E., VAN GELDEREN, J.G., HOGENBOOM, F., HEIJNA, M.H. & MULDER, A.H. (1988). μ-, δ- and κ-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur. J. Pharmacol., 154, 169-178.
46. SENUT, M.C., MENETREY, D. & LAMOUR, Y. (1989). Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm agglutinin-apohorseradish peroxidase-gold immunohistochemical study. Neuroscience, 30, 385-403.
47. SKOFITSCH, G. & JACOBOWITZ, D.M. (1985). Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides, 6, 509-546.
48. 125I-galanin binding sites in the rat central nervous system. Peptides, 7, 1029-1042.
49. SUNDSTROM, E., ARCHER, T., MELANDER, T. & HÖKFELT, T. (1988). Galanin impairs acquisition but not retrieval of spacial memory in rats studied in the Morris swim maze. Neurosci. Lett., 88, 331-335.
50. TATEMOTO, K., RÖKAEUS, A., JÖRNVALL, H., MCDONALD, T.J. & MUTT, V. (1983). Galanin - a novel biologically active peptide from porcine. FEBS Lett., 164, 124-128.
51. WENK, G.L. & RÖKAEUS, A. (1988). Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in hippocampus and neocortex. Brain Res., 460, 17-21.
52. YOSHIDA, S., NABESHIMA, T., KINBARA, K. & KAMEYAMA, T. (1992). Effects of NIK-247 on CO-induced impairment of passive avoidance in mice. Eur. J. Pharmacol., 214, 247-252.
53. ZAGER, E.L. & BLACK, P.M. (1985). Neuropeptides in human memory and learning processes. Neurosurgery, 17, 355-369.